{"id":15829,"name":"Ysios Capital","slug":"ysios-capital","website":"https://ysioscapital.com","hqGeo":"Switzerland, Denmark, Spain, France","stageFocus":["Seed"],"sectorTags":["Healthcare","EdTech"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Life sciences investor financing highly innovative biotech companies developing novel therapies for indications with high unmet medical needs. Best for deep scientific biotech rather than general software, but directly aligned on sector.","thesisNarrative":null,"logoUrl":null,"aumUsd":500000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"ReproNovo","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops novel therapies in reproductive medicine and women’s health","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Memo Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapeutic antibodies for viral infections and cancer","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Engrail Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Clinical-stage neuroscience company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Fusion Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops radiopharmaceutical cancer therapies","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Neurona Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops regenerative cell therapies for neurological disorders","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Kynexis","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops a drug for cognitive impairment in schizophrenia","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Tagworks Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Mineralys Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies for hypertension","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Northsea Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops therapies for NASH and other metabolic, inflammatory, and fibrotic diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cytoki Pharma","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Develops protein drugs, including a long-acting IL-22 program for inflammatory bowel disease and related indications","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Adcendo","companyUrl":null,"stage":"Not specified in the source","sector":"Oncology / biotech","investmentYear":null,"description":"Develops antibody-drug conjugates for targeted cancer therapy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"LAVA Therapeutics","companyUrl":null,"stage":"Not specified in the source","sector":"Oncology / immunotherapy","investmentYear":null,"description":"Develops a bispecific antibody platform engaging gamma-delta T cells for cancer treatment","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"VarmX","companyUrl":null,"stage":"Not specified in the source","sector":"Hematology / biotech","investmentYear":null,"description":"Develops therapeutic proteins to prevent and treat bleeding","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Anaconda Biomed","companyUrl":null,"stage":"Not specified in the source","sector":"Medtech / neurovascular","investmentYear":null,"description":"Develops medical devices for stroke treatment","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":8,"partners":[{"id":51651,"name":"Unknown","title":"Partner","seniority":null,"focusTags":["Biotech","Life sciences"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51644,"name":"Karen Wagner","title":"General Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/karen-ina-wagner","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51646,"name":"Guillem Laporta","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/guillem-laporta-cfa-a206977","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51649,"name":"Catalina Cuchy","title":"Executive Assistant","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/catalinacuchy","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":52577,"name":"Jordi Xiol","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51643,"name":"Arturo Urrios","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/arturourrios","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":52575,"name":"Joan Perelló","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":52576,"name":"Cristina Garmendia","title":"General Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":1026,"name":"Fund II","vintageYear":2021,"sizeUsd":200000000,"status":"investing","focusAreas":[]},{"id":1025,"name":"Fund I","vintageYear":2019,"sizeUsd":150000000,"status":"investing","focusAreas":[]}],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"fund","title":"Raised Fund II ($200M)","url":null,"source":"fund records","occurredAt":"2021-06-30T00:00:00.000Z"},{"kind":"fund","title":"Raised Fund I ($150M)","url":null,"source":"fund records","occurredAt":"2019-06-30T00:00:00.000Z"}],"contentUpdatedAt":"2026-10-27T01:32:09.413Z","investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-25T15:29:12.456Z"}